Alnylam Pharmaceuticals (NASDAQ: ALNY)
Alnylam Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Alnylam Pharmaceuticals Company Info
Alnylam Pharmaceuticals, Inc. is a global commercial-stage biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. Its products include ONPATTRO, GIVLAARI, and OXLUMO. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.
News & Analysis
Why Alnylam Pharmaceuticals Stock Is Sinking Today
Alnylam's change to a key clinical trial design appears to have worried investors more than a small Q4 revenue miss.
2 Growth Stocks That Could Rocket Higher Before the End of 2023
Potential approvals of new medicines expected soon could push these stocks through the roof.
Why Alnylam Pharmaceuticals Topped the Market Today
Monday was a good day for biotechs fighting the good fight against a common degenerative brain disorder.
3 Biopharmas on Buyout Watch
These three biotech companies could be headed for a buyout soon.
Is This Unknown Growth Stock a Buy After Its Blast Off?
It's pursuing a smart and tightly focused drug development strategy that could pay off big.
Why Alnylam Pharmaceuticals Stock Is Vaulting Higher Today
The RNAi drugmaker hits the mark in a rare form of heart failure.
Alnylam's Strategy Is Getting Bigger. Time to Buy?
After decades of developing rare-disease drugs, this RNA pioneer will aim for much larger audiences.
3 Can't-Miss Biotech Events Coming Up in 2022
This could be a very exciting year for these drugmakers.
Valuation
Podcast Episodes
Earnings Transcripts
Alnylam Pharmaceuticals, inc (ALNY) Q3 2021 Earnings Call Transcript
ALNY earnings call for the period ending September 30, 2021.
Alnylam Pharmaceuticals, inc (ALNY) Q2 2021 Earnings Call Transcript
ALNY earnings call for the period ending June 30, 2021.
Alnylam Pharmaceuticals Inc (ALNY) Q1 2021 Earnings Call Transcript
ALNY earnings call for the period ending March 31, 2021.
Alnylam Pharmaceuticals Inc (ALNY) Q4 2020 Earnings Call Transcript
ALNY earnings call for the period ending December 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.